A study reveals racial and ethnic disparities in access to Novo Nordisk's diabetes and weight loss drugs among U.S. military veterans. Black, Asian, and Native American patients are less likely to ...

(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for ...

They are expected to act as a catalyst in medicine, society, the economy, and even in... fuel consumption - The astounding ...

In September, the company officially relocated its headquarters from a 114,000-square-foot space in New York City to a ...

Nearly all the patients had Type 2 diabetes. Over three years, researchers tracked those who were prescribed either a GLP-1 drug like Ozempic or an SGLT2 medication like Jardiance after their initial ...

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy ... in a ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The correlation between the rise of these appetite-suppressing drugs and the decline in snack sales suggests that as more ...